MEDICAL DEPARTMENT UNIVERSITY OF … › en › cvDep › 145EN.pdfDec. 2013 – Apr.2015 Lecturer...
Transcript of MEDICAL DEPARTMENT UNIVERSITY OF … › en › cvDep › 145EN.pdfDec. 2013 – Apr.2015 Lecturer...
DR THEODORA KERENIDI
ASSISTANT PROFESSOR OF PULMONOLOGY
SPECIALIZED IN THORACIC ONCOLOGY
HEAD OF THORACIC ONCOLOGY ASSEMBLY
OF HELLENIC THORACIC SOSIETY
MEDICAL DEPARTMENT
UNIVERSITY OF THESSALY,
LARISSA, GREECE
CURRICULUM VITAE
Larissa 2015
THEODORA KERENIDI
CURRICULUM VITAE
2 of 15
CONTENTS
I. PERSONAL DETAILS .................................................................................................................................3
II. EDUCATION ................................................................................................................................................3
III. PROFESSIONAL DEVELOPMENT .....................................................................................................3
IV. POSTGRADUATE TRAINING...............................................................................................................4
V. AWARDS ........................................................................................................................................................6
VI. RESEARCH GRANTS ...............................................................................................................................7
VII. RESEARCH EXPERIENCE ....................................................................................................................8
PHD THESIS ......................................................................................................................................................8 PUBLICATIONS ................................................................................................................................................8 BOOK CHAPTERS .......................................................................................................................................... 10 PRESENTATIONS IN CONGRESSES ........................................................................................................ 11
VIII. REVIEWER ............................................................................................................................................ 12
IX. MEMBERSHIPS ....................................................................................................................................... 12
X. CLINICAL EXPERIENCE ........................................................................................................................ 13
XI. TEACHING EXPERIENCE .................................................................................................................... 13
UNDERGRADUATE LEVEL ........................................................................................................................... 13 POSTGRADUATE LEVEL .............................................................................................................................. 14 PHD LEVEL....................................................................................................................................................... 15
XII. SELECTED INVITED TALKS............................................................................................................. 15
THEODORA KERENIDI
CURRICULUM VITAE
3 of 15
I. PERSONAL DETAILS
NAME: Theodora Kerenidi
DATE OF BIRTH: 16 February 1971
PLACE OF BIRTH: Larissa, Greece
FAMILY STATUS: Married, one child
WORK ADDRESS: University Hospital of Larissa, Respiratory Department
411 10 Larissa, Greece
Τel.: +30 2413 50-2894, -2896
E-mail: [email protected]
LANGUAGES: Greek, English and Russian
II. EDUCATION
2008 PhD, Medical School, University of Thessaly, Greece.
2003 Medical Specialty of Respiratory Physician, 8th Pulmonology Department of the
“Sotiria” Chest Hospital of Athens, Greece.
1995 MD, Medical Institute of Lvov – Ukraine, Recognition by Hellenic Government
10/212/96
General Graduation Rate: 9.70 out of 10,
Prize and distinction awards in each year
1988 High School “Polycladiko” Experimental Lyceum, Volos Greece. (Prize and distinc-
tion awards in each year)
III. PROFESSIONAL DEVELOPMENT
May 2015- present: Assistant Professor of Pulmonology Medical School, Univer-
sity of Thessaly
Dec. 2013 – Apr.2015 Lecturer of Pulmonology, Medical School, University of
Thessaly
Sep.2010–Dec. 2013: Research Associate, Respiratory Medicine Department, Uni-
versity of Thessaly
Oct. 2012-Dec. 2013: Associate Consultant, Private General Hospital “IASO” Thes-
saly, Larissa, Greece
Sep.2009–Aug. 2010: Associate on the Lecturer’s grade, Respiratory Medicine De-
partment, University of Thessaly
THEODORA KERENIDI
CURRICULUM VITAE
4 of 15
Oct.2005 - Mar.2009: Consultant, Respiratory Medicine Department, University of
Thessaly
May.2003– Oct.2005: Research Associate, Respiratory Medicine Department, Uni-
versity of Thessaly
Dec.1997– Jan. 2003: Resident in Pneumonology, 8th Pulmonology Department of
the “Sotiria” General Hospital of Chest Diseases, Athens,
Greece
Pulmonary Fellow, Intensive Care Unit, (6 months), Center
for Respiratory Failure,“Sotiria” General Hospital for Chest
Diseases, Athens, Greece
Pulmonary Fellow, Internal Medicine, (18 months), “Sotiria”
General Hospital for Chest Diseases, Athens, Greece
Aug.1996–Dec. 1997: Medical Rural Practice (Internal Medicine), Regional Office
Stomio, Health Center Gonnoi, General Hospital of Larissa,
Greece.
IV. POSTGRADUATE TRAINING
Honorary Fellow in Lung Unit, Royal Marsden Hospital NHS, London, UK (April-July
2009).
Postgraduate training in Thoracic Oncology under the supervision of Dr. C. Nutting,
Dr. S. Popat and Dr M. O’ Brien, in Lung Cancer unit.
CONTINUING MEDICAL EDUCATION
I have attended 22 International and 24 Greek training courses:
SELECTED TRAINING COURSES
1. Targeted Therapy in Lung Cancer, ERS Research Seminar, Paris, 6-7/05/2015
2. EnGAging an Interdisciplinary Team for NSCLC Diagnosis, Personalized Assessment
and Treatment (GAIN) Non-Small Cell lung Cancer Summit, Europe, organised by
American Society for Clinical Pathology, American College of Chest Physicians, and
France Foundation, Athens, Greece, 24/02/2014.
3. Presentation skills for Health professionals, Management Development Institute,
Thessaloniki, 13-14/12/2013.
4. Experience Exchange Meeting for NSCLC, Portaria, Pilio, Greece 7-8/07/2012.
5. International Postgraduate Symposium on Lung Cancer, Samos, Greece 10-
13/06/2010 (CME 15).
THEODORA KERENIDI
CURRICULUM VITAE
5 of 15
6. 11th European Perspectives in Lung Cancer, Amsterdam, Netherlands 5-6/3/2010
(CME 12).
7. Lung Cancer Preceptorship Meeting, Montefiore Medical Center and Albert Einstein
College of Medicine, New York, USA 10-11/09/2009.
8. 10th European Perspectives in Lung Cancer, Brussels, Belgium 6-7/3/2009 (CME 12).
9. 6th Postgraduate ERS Seminar “Medical Thoracoscopy”, Alexandroupolis, Greece 3-
5/11/2008.
10. Postgraduate Seminar on Lung cancer, Santorini, Greece 1-4/5/2008 (CME 10).
11. Preceptorship Meeting, Hospital Grosshansdorf, Hamburg, Germany 4–5/4/2008.
12. 8th European Perspectives in Lung Cancer, Seville, Spain 2-3/3/2007 (CME 12).
13. 7th European Perspectives in Lung Cancer, Athens, Greece 8-9/9/2006 (CME 12).
14. ERS School Seminar “Lung Cancer: new aspects in the treatment of Lung Cancer”
Thessaloniki, Greece 1/12/2005 (CME 2.5).
15. 6th European Perspectives in Lung Cancer, Amsterdam, Netherlands 9-10/12/2005
(CME 12).
16. ESMO Advance Course “New perspectives: Chest tumours, integration of research and
treatment”, Rodos, Greece 17-19/06/2004.
I have attended 55 International and Greek Congresses:
SELECTED INTERNATIONAL CONGRESSES
1. The European Lung Cancer Conference, Geneva, Switzerland: 15-18/04/2015.
2. 3rd LUNG CANCER Network "From the Bench to the Bedside", Athens, Greece 31/1–
1/2/2014.
3. 2nd Lung Cancer Network “From the Bench to the Bedside”, Athens 03-04/02/2012,
(ESMO-MORA 1 and CME 9) Εuropean Respiratory Society Annual Congress 2012, Vi-
enna 1-5/09/2012 (CME=15).
4. Lung Cancer Network, Athens, Greece 22-23/01/2010 (CME 9).
5. Εuropean Respiratory Society Annual Congress 2009, Vienna 12-16/09/2009
(CME=15).
6. 19th International Congress on Anti Cancer Treatment, Paris, France, 5-8/02/2008.
7. 9th European Congress, Perspectives in Lung Cancer, Turino, Italy 14-15/3/2008 (CME
12).
8. Εuropean Respiratory Society Annual Congress 2008, Berlin 4-8/10/2008 (CME=15).
THEODORA KERENIDI
CURRICULUM VITAE
6 of 15
9. 12th World Conference on Lung Cancer, Seoul, Korea 1-5/09/2007 (CME 23.5).
10. The American Society of Clinical Oncology (ASCO) Annual Meeting 2007, Chicago, USA
1-5/06/2007.
11. 5th International Congress on Lung Cancer. Hellenic Society Against Lung Cancer, Pa-
tras, Greece 24-27/01/07 (CME 21).
12. 10th Central European Lung Cancer Conference, Prague, Czech Republic 18-21/6/2006.
13. Εuropean Respiratory Society Annual Congress 2006, Munich, Germany 2-6/9/2006.
14. 11th World Conference on Lung Cancer, Barcelona, Spain 3-6/7/2005 (CME 21).
15. Εuropean Respiratory Society Annual Congress 2004, Glasgow 4-8/09/2004.
V. AWARDS
1. Meritorious award for the best presentation in Lund cancer, 21th Congress of Hellenic
Thoracic Society, Athens, Greece, 2012:
Maragozidis P, Papanastasi E, Papadopoulos D, Kazakou A, Del Vescovo V, Denti M,
Kerenidi T, Gourgoulianis K. Balatsos N. Biological significance of human apoadenyl-
ases and its role in Lung Cancer.
2. Meritorious award for the best presentation in COPD, 19th Congress of Hellenic Tho-
racic Society, Rodos, Greece, 2010:
Liadaki K, Kerenidi T, Mamara A, Bardaka F, Gourgoulianis K, Speletas M. TACI and
BAFF-R expression in COPD patients.
3. Prize for the best research work in Thoracic Oncology, 18th Congress of Hellenic Tho-
racic Society, Thessaloniki, Greece, 2009:
Kerenidi T, Katsabeki A, , Dalaveris E, Kiropoulos T, Gourgoulianis K. Clinical sig-
nificance of elevated Vascular endothelial growth factor and oxidative stress serum
levels in patients with primary lung cancer.
4. Meritorious award for the best presentation in lung cancer, 17th Congress of Hellenic
Thoracic Society, Alexandroupoli, Greece, 2008:
Kerenidi T, Zamanakou M, Tsochas S, Nakou M, Poularakis T, Chevas A, Dahadreh J
Gourgoulianis KI, Germenis AE, Karanikas V. Transcriptional Expression of Human
Telomerase Reverse Transcriptase (hTERT) and Indoleamine 2,3-Dioxygenase (IDO)
in Non-Small Cell Lung Cancer.
5. 1st Prize, Best presentation Award for “New Horizons in Cancer Research, 40 Interna-
tional congress of Biotechnology (IGBF), Athens, 2-3/02/2008:
Karanikas V, Tsochas S, Boukas K, Kerenidi T, Nakou M, Dahabreh J, Poularakis T,
THEODORA KERENIDI
CURRICULUM VITAE
7 of 15
Gourgoulianis KI, Germenis AE. Co-expression patterns of tumor-associated antigen
genes by non-small cell lung carcinomas: Implications for Immunotherapy.
6. 2nd Prize, Best presentation Award, 16th Congress of Hellenic Thoracic Society, Ath-
ens, Greece, 2007:
Karanikas V, Zamanakou M, Speletas M, Loules G, Kalala F, Kerenidi T, Nakou M,
Dahabreh J, Gourgoulianis KI, Germenis AE. Foxp3 expression in Lung cancer.
7. Meritorious award for the best presentation in lung cancer, 16th Congress of Hellenic
Thoracic Society, Athens, Greece, 2007:
Dalaveris E, Kerenidi T, Katsabeki A, Tanou K, Kiropoulos T, Gogou E, Gourgoulianis
K, Kostikas K, , Pretreatment levels of VEGF and 8- isoprostaine in exhaled breath
condensate and serum of lung cancer patients.
8. 1st Prize, “Sotiris Papastamatis” Award, 330 Congress of Hellenic Medical Society, Ath-
ens, Greece, 2007:
Karanikas V, Speletas M, Zamanakou M, Kalala F, Loules G, Kerenidi T, Gourgoulian-
is KI, Germenis AE. Foxp3 expression in human cancer cells and tissue.
VI. RESEARCH GRANTS
I have participated as a co-investigator in the following successful grants:
- Two clinical research grants from the Hellenic Thoracic Society at 2009 and 2001
(each 15,000€).
- Four research grants from Pharmaceutical Companies (GlaxoSmithKline ELLAS AE,
Boehringer Ingelheim ELLAS AE, ELPEN AE.) 2012-2014, (total 41,000€).
- RENEWING HEALTH (REgioNs of Europe WorkINg toGether for HEALTH), Grant
Agreement No 250487, 2010 (30,000€).
- EU Marie Curie International Re-Integration Grant, EU046459–IMMUNOEPIGENETICS,
2007 (80,000€).
- ΕPΑΝ – General Secretariat for Research and Technology: «Collaboration with Re-
search Organisations outside Europe - 2005» (05-NON-EU 445), 2006 (67,000€)
- ΕΝΤΕΡ2004 – General Secretariat for Research and Technology (04ΕΡ09), 2006
(78,000€).
- EU Marie Curie Incoming International Fellowship, EU 021975-IRTALUNG, 2005
(186,000€).
- ΕPΕΑΕΚ II: Pythagoras II – Support of University Research Teams (52211.11), 2005
THEODORA KERENIDI
CURRICULUM VITAE
8 of 15
(100,000€).
VII. RESEARCH EXPERIENCE
My primary research field is thoracic oncology. In particular, I have performed
extensive research in the following two areas: diagnostic and prognostic biomarkers in
lung cancer patients; and the immunologic aspects of lung cancer and more precisely
the anti-tumour immune response.
PhD THESIS
Obtained my PhD degree at the University of Thessaly, Greece (2008). The sub-
ject of my thesis was “Transcriptional Expression of Human Telomerase Reverse Tran-
scriptase (hTERT) and Indoleamine 2,3-Dioxygenase (IDO) in Lung Cancer”.
Supervisors: Prof K. Gourgoulianis and Prof A. Germenis.
PUBLICATIONS
My research has been published in more than 26 articles, letters or book chap-
ters indexed in pubmed, scopus ets., including at prestigious international journals
such as Cancer Letters, Immunology and Cell Biology, Lung Cancer. They have more
than 263 citations (h-factor 8) and have received 7 awards.
1. VAVOUGIOS G, KERENIDI T, TSILIONI I, ZAROGIANNIS S, GOURGOULIANIS KI. Pleu-
ral effusion levels of DJ-1 are increased in elderly lung cancer patients with
malignant pleural effusions. Redox Rep 2015, Jun 30.
2. KERENIDI T, LADA M, TSAROUCHA A, GEORGOULIAS P, MYSTRIDOU P,
GOURGOULIANIS KI. Clinical significance of serum adipokines levels in lung can-
cer. Med Oncol 2013;30(2):507.
3. PAPALA M, KERENIDI N, GOURGOULIANIS KI. Everyday clinical practice and its re-
lationship to 2010 and 2011 GOLD guideline recommendations for the man-
agement of COPD. Prim Care Respir J 2013;22(3):362-4.
4. STAFYLA E, KERENIDI T, GOURGOULIANIS KI. Chronic obstructive pulmonary dis-
ease exacerbation frequency and severity. Int J Chron Obstruct Pulmon Dis
2013;8:533-5.
5. ZAROGOULIDIS P, GLAROS D, KONTAKIOTIS T, FROUDARAKIS M, KIOUMIS L,
KOUROUMICHAKIS L, TSIOTSIOS A, KALLIANOS A, STEIROPOULOS P, PORPODIS K,
NENA E, PAPAKOSTA D, RAPTI A, CONSTANTINIDIS TC, KERENIDI T, PANOPOULOU M,
TRAKADA G, COURCOUTSAKIS N, FOUKA E, ZAROGOULIDIS K, MALTEZOS E. Health
THEODORA KERENIDI
CURRICULUM VITAE
9 of 15
costs from hospitalization with H1N1 infection during the 2009-2010 influenza
pandemic compared with non-H1N1 respiratory infections. Int J Gen Med
2012;5:175-82.
6. ZAROGOULIDIS P, KERENIDI T, HUANG H, KONTAKIOTIS T, TREMMA O, PORPODIS K,
KALIANOS A, RAPTI A, FOROULIS C, ZISSIMOPOULOS A, COURCOUTSAKIS N,
ZAROGOULIDIS K. Six minute walking test and carbon monoxide diffusing capac-
ity for non-small cell lung cancer: easy performed tests in every day practice. J
Thorac Dis 2012;4(6):569-76.
7. KARETSI E, IOANNOU MG, KERENIDI T, MINAS M, MOLYVDAS PA, GOURGOULIANIS
KI, PARASKEVA E. Differential expression of hypoxia-inducible factor 1α in non-
small cell lung cancer and small cell lung cancer. Clinics 2012;67(12):1373-8.
8. ZAROGOULIDIS P, KOULIATSIS G, PAPANAS N, SPYRATOS D, CONSTANTINIDIS TC,
KOUROUMICHAKIS I, STEIROPOULOS P, MABROUDI M, MATTHAIOS D, KERENIDI T,
COURCOUTSAKIS N, ZAROGOULIDIS K, MALTEZOS E. Long-term respiratory follow-
up of H1N1 infection. Virol J 2011;8:319. (Highly accessed)
9. KARANIKAS V, ZAMANAKOU M, SOUKOU F, KERENIDIT, GOURGOULIANIS KI,
GERMENIS AE. Naturally occurring tumor-specific CD8(+) T-cell precursors in i
ndividuals with and without cancer Immunol Cell Biol 2010;88(5):575-85.
10. BARTZIOKAS K, DAENAS C, PREAU S, ZYGOULIS P, TRIANTARIS A, KERENIDI T,
MAKRIS D, GOURGOULIANIS KI, DANIIL Z. Vibration response imaging: evaluation
of rater agreement in healthy subjectsand subjects with pneumonia. BMC Med
Imaging 2010, 10:6.
11. KARANIKAS V, ZAMANAKOU M, SOUKOU F, KERENIDI T, TSOUGOS I, THEODOROU K,
GEORGOULIAS P, GOURGOULIANIS KI, GERMENIS AE. Cytolytic T-cell response
against Epstein-Barr virus in lung cancer patients and healthy subjects. J Exp
Clin Cancer Res 2010;29:64
12. DALAVERIS E, KERENIDI T, KATSABEKI-KATSAFLI A, KIROPOULOS T, TANOU K,
GOURGOULIANIS KI, KOSTIKAS K. VEGF, TNF-α and 8-isoprostane levels in ex-
haled breath condensate and serum of patients with lung cancer Lung Cancer
2009, 64:219-25
13. KATSABEKI-KATSAFLI A, KERENIDI T, KOSTIKAS K, GOURGOULIANIS KI. Response
to"Serum vascular endothelial growth factor is related to systemic oxidative
stress in patients with lung cancer" (Letter, Authors' Reply) Lung Cancer 2009,
65:254-5
14. KARANIKAS V, KHALIL S, KERENIDI Τ, GOURGOULIANIS KΙ, GERMENIS AΙ. Αnti-
survivin antibody responses in lung cancer Cancer Lett 2009, 282:159-66
THEODORA KERENIDI
CURRICULUM VITAE
10 of 15
15. IOANNOU M, PAPAMICHALI R, KOUVARAS E, MYLONIS I, VAGELI D, KERENIDOU T,
BARBANIS S, DAPONTE A, SIMOS G, GOURGOULIANIS K, KOUKOULIS GK. Hypoxia
Inducible Factor-1alpha and Vascular Endothelial Growth Factor in Biopsies of
Small Cell Lung Carcinoma Lung 2009, 187:321-9
16. GOGOU E, KERENIDI TH, CHAMOS V, ZINTZARAS E, GOURGOULIANIS KI. Mesotheli-
oma Mortality in Greece from 1983 to 2003 Int J Clin Pract 2009, 63:944-8
17. KOUTSOKERA A, PAPAIOANNOU A, MALLI F, KATSABEKI A, KIROPOULOS T, KERENIDI
T, GOURGOULIANIS KI, DANIIL Z. Systemic oxidative stress in patients with pul-
monary sarcoidosis Pulm Pharmacol Ther 2009, 22:603-7
18. KATSABEKI-KATSAFLI A, KERENIDI T, KOSTIKAS K, DALAVERIS E, KIROPOULOS TS,
GOGOU E, PAPAIOANNOU AI, GOURGOULIANIS KI. Serum Vascular endothelial
growth factor is related to systemic oxidative stress in patients with lung can-
cer. Lung Cancer 2008, 60:271-6
19. KARANIKAS V, SPELETAS M, ZAMANAKOU M, KALALA F, LOULES G, KERENIDI T,
GOURGOULIANIS KI, GERMENIS AE. Foxp3 expression in human cancer cells. J
Translational Med 2008, 6:19
20. KARANIKAS V, SOUKOU F, KALALA F, KERENIDI T, GRAMMOUSTIANOU E,
GOURGOULIANIS KI, GERMENIS AE. Baseline levels of CD8+ T cells against sur-
vivin and survivin-2B in the blood of lung cancer patients and cancer-free indi-
viduals. Clin Immunol 2008, 129:230-40
21. GOGOU E, KERENIDI T, CHAMOS V, HATZOGLOU CH, GOURGOULIANIS KI. Environ-
mental asbestos exposure alters the male:female ratio in patients with pleural
mesothelioma. Respirology 2008, 13:931
22. KARANIKAS V, ZAMANAKOU M, KERENIDI T, DAHABREH J, HEVAS A, NAKOU M,
GOURGOULIANIS KI, GERMENIS AE. Indoleamine 2,3-dioxygenase (IDO) expres-
sion in lung cancer Cancer Biol Ther 2007, 6:1258-62
23. KARANIKAS V, TSOHAS S, BOUKAS K, KERENIDI T, NAKOU M, DAHABREH J,
POULARAKIS T, GOURGOULIANIS KI, GERMENIS AE. Co-expression patterns of tu-
mor-associated antigen genes by non-small cell lung carcinomas: Implications
for immunotherapy Cancer Biol Ther 2007, 7:345-52.
BOOK CHAPTERS
1. KERENIDI T, GOURGOULIANIS K. Long-term progression free survival with Erlo-
tinib as switch maintenance therapy in a patient with squamous cell carcinoma
THEODORA KERENIDI
CURRICULUM VITAE
11 of 15
of the lung. Ιn: Syrigos K. (Editor), Erlotinib in Lung Cancer: Impact & Exceptional
Cases, Focus on Health Ltd Publications, Athens 2014;209-213.
2. KERENIDI T, SYRIGOS K. Angiogenesis, Antiangiogenesis Strategy and Angio-
genesis Inhibitors. Ιn: Malay Chatterjee (Editor), Angiogenesis and Therapeutic tar-
gets in Cancer, Bentham e-Books Science Publisher Chapter
DOI:10.2174/978160805007911001010001, 2010;1-17.
3. KERENIDI T. The Solitary pylmonary nodule, .In: Dimopoulos P.et al. (Editors)
Lung Cancer, Current Diagnosis and Treatment, Patras 2007;8:75-83.
PRESENTATIONS IN CONGRESSES
I have contributed and presented over 40 abstracts (6 oral presentations) to Interna-
tional Congresses and 61 abstracts (29 oral presentations) to Greek Congresses.
Selected Presentations in International Congresses
1. Kerenidi T, Stafyla E, Dafoulas G, Giannakakos H, Pinaka M, Karetsi E, Stafylas P,
Theodorou K, Pexlivanoglou P, Mavrodi F, Aletras V, Gourgoulianis K.
Shortterm telemonitoring program after hospital discharge for COPD exacerbation: Greek pilot of
the Renewing Health multicenter randomized trial. ERS Annual Congress, 26-30/09/2015
2. Kalkanis Α, Varsamas Ch, Kerenidi T, Gourgoulianis K, Daniil Z. Correlation of pleural
effusions’ grayscale sonographic parameters with fluid’s analysis results. ERS Annual
Congress, 26-30/09/2015.
3. Lamprodimou G, Athanasiadis A, Kerenidi T, Doufexis D, Lada M, Tsilioni I, Roussos G,
Vavougios G, Gourgoulianis K. Clinical significance of cytokines levels in exhaled
breath condensate (EBC) and serum of lung cancer patients. ASCO Annual Congress, J
Clin Oncol 31, 2013 (suppl; abstr e22202)
4. Vageli D, Doukas S, Kerenidi T, Koukoulis GK, Gourgoulianis KI, Daniil Z. Correlation
of miR-422a, miR-21 and miR-155 analysis with hMSH2 and hMLH1 mRNA expression
profiles in non-small cell lung carcinomas and their adjacent normal tissues. ERS An-
nual Congress, European Respiratory Journal 2013 (P4639)
5. Vavougios G, Kerenidi T, Tsilioni I, Gourgoulianis K. The protein DJ-1 in malignant
pleural effusions due to lung cancer: Levels and correlations with oxidative stress bi-
omarkers. ERS Annual Congress, European Respiratory Journal 2013 (P2914)
THEODORA KERENIDI
CURRICULUM VITAE
12 of 15
6. Kazakou A, Kerenidi T, Lada M, Tsilioni I, Dalaveris E, Gourgoulianis K.I. Clinical sig-
nificance of serum osteopontin levels in lung cancer. ERS Annual Congress, European
Respiratory Journal 2012 (P4210).
7. Kerenidi T, Zamanakou M, Tsochas S, Karanikas V, Germenis AE, Gourgoulianis
KI.Transcriptional Expression of Human Telomerase Reverse Transcriptase (hTERT) and
Indoleamine 2,3-Dioxygenase (IDO) in Non-Small Cell Lung Cancer. ERS Annual Con-
gress, Εuropean Respiratory Journal 2010 (P3254).
8. Tsilioni I, Kerenidi T, Lada M, Oikonomidi S, Kiropoulos T, Gourgoulianis K. Elevated
serum levels of oxidative stress biomarkers in patients with lung cancer. ERS Annual
Congress, Εuropean Respiratory Journal 2010 (P3250)
9. Kerenidi T, Tsaroucha A, Lada M, Georgoulias P, Mystridou P, Gourgoulianis K, Kostikas
K. Clinical significance of serum adipokines levels in lung cancer. ERS Annual Con-
gress, Εuropean Respiratory Journal 2009, 34:53 (Suppl.), 475-475.
10. Katsampeki-Katsafli A, Kerenidi T, Kostikas K, Kiropoulos T, Dalaveris E, Gourgoulianis
KI. High pre-treatment serum levels of VEGF and oxidative stress in lung cancer pa-
tients and their clinical implications. Journal of Thoracic Oncology 2008,
3:4(Suppl.1):43-43.
VIII. REVIEWER
Lung
Cancer Gene Therapy
Recent Patents on Anti-Cancer Drug Discovery
International Journal of Genetics and Molecular Biology
Pneumon
Investigational New Drugs
Journal of Medical Case Reports
Renal failure
Case Reports in Ophthalmology
IX. MEMBERSHIPS
HELLENIC THORACIC SOSIETY
Head of Thoracic Oncology Assembly
GREEK UNION OF PULMONOLOGISTS
EUROPEAN RESPIRATORY SOCIETY (ERS)
THEODORA KERENIDI
CURRICULUM VITAE
13 of 15
Member of Thoracic Oncology Assembly
NATIONAL LUNG CANCER PARTNERSHIP
WOMAN AGAINST LUNG CANCER IN EUROPE
X. CLINICAL EXPERIENCE
During the last 12 years, I have acquired an extensive and comprehensive experience
of the clinical work of the Pulmonary Clinic, through my positions as a Research Associate
at the Pulmonary Department (2003-2005 and 2009-2013), as a consultant (2005-2009)
and as a Lecturer and Ass. Prof. of Pulmonology (2013-present). A focal point of my clinical
work was on the diagnostic and therapeutic assessment of oncology patients with lung can-
cer.
More precisely, my clinical experience includes the following:
- In charge of the diagnostic and therapeutic approach for a large number of hospital-
ized patients with all kind of respiratory diseases (12 years)
- In charge of the diagnostic and therapeutic approach, palliative care and follow up of
oncology patients with lung cancer (12 years).
- Organisation and direction of two special regular outpatient clinics, the Thoracic on-
cology outpatient clinic (2007-2010) and the Clinic of Chronic Obstructive Pulmonary
Disease (2009-present).
- Regular participation in the Emergency Department of the hospital (5 years)
- Regular participation in the pulmonary outpatient clinic where over 100 patients are
evaluated monthly. (12 years)
XI. TEACHING EXPERIENCE
UNDERGRADUATE LEVEL
- Regular participation in the teaching of several courses to Medical students of the
University of Thessaly since 2008:
Pathophysiology of the Respiratory system
Respiratory Medicine
Internal Medicine
Biomedical communication
THEODORA KERENIDI
CURRICULUM VITAE
14 of 15
POSTGRADUATE LEVEL
- Scientific coordination of 3 Courses (1.Biomedical communication, 2. Lectures on Pre-
vention in Primary Health Care and 3. Clinical training in Primary Health Care) in
postgraduate program (Master) “Primary Health Care”, Medical Department, Univer-
sity of Thessaly, Greece (2011-13, 2012-14, 2013-15, 2014-16)
- Supervision of 10 Master theses (7 completed and 3 in progress) in postgraduate pro-
gram “Primary Health Care”, Medical Department, University of Thessaly, Greece
since 2005.
- Scientific coordination of 1 Course (Inter-professional collaboration) in postgraduate
program (Master) “Exercise, Ergospirometry, Rehabilitation”, Medical Department,
University of Thessaly, Greece (2014-16)
- Postgraduate Program (Master), Department of Biochemistry & Biotechnology, Uni-
versity of Thessaly, "Applications of Molecular Biology - Genetics - Diagnostic Mark-
ers” in course " Molecular Diagnosis of Cancer "with the lecture "Molecular Diagnosis
and Clinical Applications in oncology? The example of lung cancer. " (2012-14, 2013-
15, 2014-16)
- Postgraduate Program (Master), Oncology Unit, GPP, “Sotiria” Hospital, Athens School
of Medicine “Thoracic Oncology" with the lecture “Neoadjuvant chemotherapy in
NSCLC." (2010-12)
- Educational Seminar “Education in Pulmonology: Combining documented theory to
clinical practice ", organized by the Hellenic Thoracic Society for Respiratory resi-
dents, with the lecture “Lung Cancer ". (every year since 2008)
- Design, organization and teaching in Asynchronous eLearning program “Diagnosis of
Respiratory Diseases (KEK120), Vocational Training Centre, University of Thessaly,
(2012-13, 2013-14, 2014-15)
- Design, organization and teaching in Asynchronous eLearning program “Career Train-
ing for Medical Office Assistants & Secretaries” (KEK118), Vocational Training Centre,
University of Thessaly, (2012-13, 2013-14, 2014-15)
- Participation in several educational programs for the residents of Radiology Depart-
ment, Surgery Department, Immunology Department and Internal Medicine Depart-
ment, Medical School, University of Thessaly by giving lectures related to thoracic ne-
oplasms.
- Participation in the weekly educational program of the Respiratory Medicine Depart-
ment, University of Thessaly with lectures regarding thoracic oncology and COPD.
THEODORA KERENIDI
CURRICULUM VITAE
15 of 15
PhD LEVEL
- Co-supervision of 8 theses (3 completed, 5 in progress)
XII. Selected Invited Talks
- I have been invited to give over 50 lectures and chaired several sessions in
Greek and International conference and seminars predominantly about diagnostic and
therapeutic approaches of patients with lung cancer.
1. Immunotherapy in Lung Cancer, Respiro Webinars, Mendor EDITIONS SA,
24/06/2015.
2. Lung Cancer in women, 23nd Congress of Hellenic Thoracic Society, Athens, Greece,
11/2014.
3. Immunotherapy in Lung Cancer, 22nd Congress of Hellenic Thoracic Society, Athens,
Greece, 12/2013.
4. Targeted therapy in locally advanced Lung Cancer. Up to date: Early and Locally ad-
vanced Non-Small Cell Lung Cancer, Athens, 13/04/2013.
5. Maintenance chemotherapy in NSCLC. 21st Congress of Hellenic Thoracic Society,
Athens, Greece, 2012.
6. From prevention to early diagnosis of Lung Cancer, 5th Central Greece Congress of
Oncology, Larissa, Greece, 2012
7. Management of Early Stage Lung Cancer, 2nd ACCP-HTS Pulmonary Board Review
Course, Athens, Greece, 2012.
8. Personalized therapy in advanced Lung Cancer. Lung Cancer Network, Athens,
Greece, 2010.
9. Systemic treatment of pleural mesothelioma. Updates in Lung and Head & Neck Can-
cers, Myconos, Greece, 2009
10. Novel vaccines – Immunotherapy, Postgraduate seminar on Lung cancer, Hellenic
Thoracic Society, Santorini Greece, 2008.
11. Adjuvant chemotherapy in NSCLC, Postgraduate seminar on Lung cancer, Hellenic
Thoracic Society, Corfu, Greece, 2008.
12. The solitary pulmonary nodule, 5th International Congress on Lung Cancer. Hellenic
Society Against Lung Cancer, Patras, Greece 2007.